Gainers
- Dakota Gold (NYSE:DC) shares rose 97.1% to $13.60 in pre-market trading. The company’s stock was uplisted to NYSE American on Tuesday.
- BigBear.ai Holdings, Inc. (NYSE:BBAI) rose 19.7% to $12.38 in pre-market trading after jumping around 18% on Tuesday.
- TransCode Therapeutics, Inc. (NASDAQ:RNAZ) rose 17.1% to $3.40 in pre-market trading.
- Alpha Tau Medical Ltd. (NASDAQ:DRTS) rose 14.5% to $14.51 in pre-market trading. Citigroup recently initiated coverage on the stock with a Buy rating and announced a $21 price target.
- Alset EHome International Inc. (NASDAQ:AEI) rose 12.6% to $0.62 in pre-market trading. Alset EHome International recently reported FY2021 results with a 22% revenue growth.
- Gogo Inc. (NASDAQ:GOGO) shares rose 11% to $21.30 in pre-market trading. Gogo recently named Sergio Aguirre as President and COO.
- Guardforce AI Co., Limited (NASDAQ:GFAI) rose 10.6% to $1.87 in pre-market trading. Guardforce AI shares gained 5% on Tuesday after the company announced it has begun to roll out additional features for its Intelligent Cloud Platform powered robots in Macau.
- Iveda Solutions, Inc. (NASDAQ:IVDA) rose 10.6% to $4.17 in pre-market trading. Iveda reported closing of $8.0 million public offering uplisting to Nasdaq and reverse stock split.
- Tuscan Holdings Corp. II (NASDAQ:THCA) rose 9.3% to $13.89 in pre-market trading after jumping around 12% on Tuesday.
- Sunshine Biopharma, Inc. (NASDAQ:SBFM) shares rose 8% to $6.06 in pre-market trading. Sunshine Biopharma shares jumped 148% on Tuesday after the company announced that two of its designed mRNA molecules are effective at destroying cancer cells grown in culture.
- Missfresh Limited (NASDAQ:MF) rose 7.8% to $1.38 in pre-market trading.
- OpGen, Inc. (NASDAQ:OPGN) rose 7.3% to $0.85 in pre-market trading. OpGen recently announced interim analysis results from clinical trial for unyvero urinary tract infection panel.
- Guardion Health Sciences, Inc. (NASDAQ:GHSI) rose 5.3% to $0.2230 in pre-market trading. Guardion Health Sciences recently reported FY21 loss of $1.04 per share.
